• +1-646-491-9876
    • +91-20-67278686

    Search

    Global Genome Editing Market 2018-2022

    Global Genome Editing Market 2018-2022

    • Report Code ID: RW00011949678
    • Category Life Sciences
    • No. of Pages 117
    • Publication Month Apr-18
    • Publisher Name Infiniti Research
    About Genome Editing

    Genome editing is a type of genetic engineering technique that involves insertions, deletions, replacements or modifications of DNA in the genomes of living organisms.

    Publisher's analysts forecast the global genome editing market to grow at a CAGR of 15.6% during the period 2018-2022.

    Covered in this report
    The report covers the present scenario and the growth prospects of the global genome editing market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

    The market is divided into the following segments based on geography:
    - Americas
    - APAC
    - EMEA

    Publisher's report, Global Genome Editing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

    Key vendors
    - Genscript
    - Horizon Discovery Group
    - Lonza
    - Merck KGaA
    - Sangamo Therapeutics
    - Thermo Fisher Scientific

    Market driver
    - Increase in applications of genome editing in therapeutics
    - For a full, detailed list, view our report

    Market challenge
    - Lack of trained laboratory professionals
    - For a full, detailed list, view our report

    Market trend
    - Global initiatives encouraging proteomics research
    - For a full, detailed list, view our report

    Key questions answered in this report
    - What will the market size be in 2022 and what will the growth rate be?
    - What are the key market trends?
    - What is driving this market?
    - What are the challenges to market growth?
    - Who are the key vendors in this market space?

    You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
    PART 01: EXECUTIVE SUMMARY
    PART 02: SCOPE OF THE REPORT
    PART 03: RESEARCH METHODOLOGY
    PART 04: MARKET LANDSCAPE
    - Market ecosystem
    - Market characteristics
    - Market segmentation analysis
    PART 05: MARKET SIZING
    - Market definition
    - Market sizing 2017
    - Market size and forecast 2017-2022
    PART 06: FIVE FORCES ANALYSIS
    - Bargaining power of buyers
    - Bargaining power of suppliers
    - Threat of new entrants
    - Threat of substitutes
    - Threat of rivalry
    - Market condition
    PART 07: MARKET SEGMENTATION BY END-USER
    - Segmentation by end-user
    - Comparison by end-user
    - Biotechnology and pharmaceutical companies
    - Academic institutes and research laboratories
    - CROs
    - Market opportunity by end-user
    PART 08: CUSTOMER LANDSCAPE
    PART 09: REGIONAL LANDSCAPE
    - Geographical segmentation
    - Regional comparison
    - Americas
    - EMEA
    - APAC
    - Market opportunity
    PART 10: DECISION FRAMEWORK
    PART 11: DRIVERS AND CHALLENGES
    - Market drivers
    - Market challenges
    PART 12: MARKET TRENDS
    - Technological advancement in genome editing tools
    - Global initiatives encouraging proteomics research
    - Advances in genome editing tools to improve development of vaccines
    PART 13: VENDOR LANDSCAPE
    - Overview
    - Landscape disruption
    PART 14: VENDOR ANALYSIS
    - Vendors covered
    - Vendor classification
    - Market positioning of vendors
    - Genscript
    - Horizon Discovery Group
    - Lonza
    - Merck KGaA
    - Sangamo Therapeutics
    - Thermo Fisher Scientific
    PART 15: APPENDIX
    - List of abbreviations
    Exhibit 01: Parent market
    Exhibit 02: Global genomics market
    Exhibit 03: Market characteristics
    Exhibit 04: Market segments
    Exhibit 05: Market definition - Inclusions and exclusions checklist
    Exhibit 06: Market size 2017
    Exhibit 07: Validation techniques employed for market sizing 2017
    Exhibit 08: Global genome editing market- Market size and forecast 2017-2022 ($ mn)
    Exhibit 09: Global genome editing market- Year-over-year growth 2018-2022 (%)
    Exhibit 10: Five forces analysis 2017
    Exhibit 11: Five forces analysis 2022
    Exhibit 12: Bargaining power of buyers
    Exhibit 13: Bargaining power of suppliers
    Exhibit 14: Threat of new entrants
    Exhibit 15: Threat of substitutes
    Exhibit 16: Threat of rivalry
    Exhibit 17: Market condition - Five forces 2017 and 2022
    Exhibit 18: End-user - Market share 2017-2022 (%)
    Exhibit 19: Comparison by end-user
    Exhibit 20: Biotechnology and pharmaceutical companies- Market size and forecast 2017-2022 ($ mn)
    Exhibit 21: Biotechnology and pharmaceutical companies - Year-over-year growth 2018-2022 (%)
    Exhibit 22: Academic institutes and research laboratories - Market size and forecast 2017- 2022 ($ mn)
    Exhibit 23: Academic institutes and research laboratories - Year-over-year growth 2018-2022 (%)
    Exhibit 24: CROs - Market size and forecast 2017-2022 ($ mn)
    Exhibit 25: CROs - Year-over-year growth 2018-2022 (%)
    Exhibit 26: Market opportunity by end-user
    Exhibit 27: Customer landscape
    Exhibit 28: Global - Market share by geography 2017-2022 (%)
    Exhibit 29: Regional comparison
    Exhibit 30: Americas - Market size and forecast 2017-2022 ($ mn)
    Exhibit 31: Americas - Year-over-year growth 2018-2022 (%)
    Exhibit 32: Top 3 countries in Americas
    Exhibit 33: EMEA- Market size and forecast 2017-2022 ($ mn)
    Exhibit 34: EMEA - Year-over-year growth 2018-2022 (%)
    Exhibit 35: Top 3 countries in EMEA
    Exhibit 36: APAC - Market size and forecast 2017-2022 ($ mn)
    Exhibit 37: APAC - Year-over-year growth 2018-2022 (%)
    Exhibit 38: Top 3 countries in APAC
    Exhibit 39: Market opportunity
    Exhibit 40: Vendor landscape
    Exhibit 41: Landscape disruption
    Exhibit 42: Vendors covered
    Exhibit 43: Vendor classification
    Exhibit 44: Market positioning of vendors
    Exhibit 45: Genscript overview
    Exhibit 46: GenScript - Business segments
    Exhibit 47: GenScript - Organizational developments
    Exhibit 48: Genscript- Geographic focus
    Exhibit 49: Genscript - Segment focus
    Exhibit 50: Genscript - Key offerings
    Exhibit 51: Horizon Discovery Group overview
    Exhibit 52: Horizon Discovery Group - Business segments
    Exhibit 53: Horizon Discovery Group - Organizational developments
    Exhibit 54: Horizon Discovery Group - Geographic focus
    Exhibit 55: Horizon Discovery Group - Segment focus
    Exhibit 56: Horizon Discovery Group - Key offerings
    Exhibit 57: Lonza overview
    Exhibit 58: Lonza - Business segments
    Exhibit 59: Lonza - Organizational developments
    Exhibit 60: Lonza - Geographic focus
    Exhibit 61: Lonza - Segment focus
    Exhibit 62: Lonza - Key offerings
    Exhibit 63: Merck KGaA overview
    Exhibit 64: Merck KGaA- Business segments
    Exhibit 65: Merck KGaA - Organizational developments
    Exhibit 66: Merck KGaA - Geographic focus
    Exhibit 67: Merck KGaA - Segment focus
    Exhibit 68: Merck KGaA - Key offerings
    Exhibit 69: Sangamo Therapeutics overview
    Exhibit 70: Sangamo Therapeutics- Business segments
    Exhibit 71: Sangamo Therapeutics- Organizational developments
    Exhibit 72: Sangamo Therapeutics - Geographic focus
    Exhibit 73: Sangamo Therapeutics - Segment focus
    Exhibit 74: Sangamo Therapeutics - Key offerings
    Exhibit 75: Thermo Fisher Scientific overview
    Exhibit 76: Thermo Fisher Scientific - Business segments
    Exhibit 77: Thermo Fisher Scientific - Organizational developments
    Exhibit 78: Thermo Fisher Scientific - Geographic focus
    Exhibit 79: Thermo Fisher Scientific - Segment focus
    Exhibit 80: Thermo Fisher Scientific - Key offerings
    Genscript
    Horizon Discovery Group
    Lonza
    Merck KGaA
    Sangamo Therapeutics
    and Thermo Fisher Scientific.

    Request for Sample

    Report Url https://www.reportsweb.com//global-genome-editing-market-2018-2022&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url https://www.reportsweb.com//global-genome-editing-market-2018-2022&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url https://www.reportsweb.com//global-genome-editing-market-2018-2022&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments